Bei Akademie registrieren
Sandoz, CH1243598427

Sandoz stock pre-market at EUR 83.41: generic drugmaker

Published on 10/19/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Generic and biosimilar medicines are Sandoz's core business. At Lang & Schwarz the stock trades pre-market at EUR 83.41 on October 19, 2026.

Business model and market

  • Sandoz develops, manufactures and markets generic and biosimilar medicines worldwide.
  • The company's home listing is SWX:SDZ in Switzerland.
  • Sandoz stock trades pre-market at EUR 83.41 at 7:45 a.m. CEST at Lang & Schwarz on October 19, 2026.
Sandoz, CH1243598427, Illustration mit AI erstellt.
Sandoz, CH1243598427, Illustration mit AI erstellt.

Sandoz develops, manufactures and markets generic and biosimilar medicines worldwide, according to Simply Wall St. Sandoz stock trades pre-market at EUR 83.41 at 7:45 a.m. CEST at Lang & Schwarz on October 19, 2026.

Ahead of the Xetra open

The pre-market indication is available before regular Xetra trading begins. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sandoz stock.

How Sandoz earns revenue

Sandoz earns revenue by developing, manufacturing and marketing generic and biosimilar medicines across global markets. The company is identified as SWX:SDZ in Switzerland. Market context: Market report SMI.

More news and analysis on Sandoz stock

Disclaimer...
en | CH1243598427 | SANDOZ | boerse | 70357573 | bgmi